0001181431-13-059304.txt : 20131115 0001181431-13-059304.hdr.sgml : 20131115 20131115190633 ACCESSION NUMBER: 0001181431-13-059304 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131113 FILED AS OF DATE: 20131115 DATE AS OF CHANGE: 20131115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUESTCOR PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000891288 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330476164 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1300 NORTH KELLOGG DRIVE STREET 2: SUITE D CITY: ANAHEIM STATE: CA ZIP: 92807 BUSINESS PHONE: 714-786-4200 MAIL ADDRESS: STREET 1: 1300 NORTH KELLOGG DRIVE STREET 2: SUITE D CITY: ANAHEIM STATE: CA ZIP: 92807 FORMER COMPANY: FORMER CONFORMED NAME: CYPROS PHARMACEUTICAL CORP DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAILEY DON M CENTRAL INDEX KEY: 0001223697 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14758 FILM NUMBER: 131225076 MAIL ADDRESS: STREET 1: 1300 N. KELLOGG DRIVE STREET 2: SUITE D CITY: ANAHEIM STATE: CA ZIP: 92607 4 1 rrd395544.xml FORM 4 X0306 4 2013-11-13 0 0000891288 QUESTCOR PHARMACEUTICALS INC QCOR 0001223697 BAILEY DON M 1300 NORTH KELLOGG DRIVE SUITE D ANAHEIM CA 92807 1 1 0 0 President and CEO Common Stock 2013-11-13 4 M 0 40000 5.10 A 139000 I Held by the Bailey 1995 Family Trust Common Stock 2013-11-13 4 S 0 2098 61.7855 D 136902 I Held by the Bailey 1995 Family Trust Common Stock 2013-11-13 4 S 0 37902 62.4742 D 99000 I Held by the Bailey 1995 Family Trust Stock Option (right to buy) 5.10 2013-11-13 4 M 0 40000 0 D 2019-02-25 Common Stock 40000 100000 I Held by the Bailey 1995 Family Trust As of the date of this Form 4, the reporting person holds Questcor Pharmaceuticals, Inc. stock options to purchase 1,105,000 shares of common stock; of such amount, 862,498 shares are fully vested and exercisable. The reporting person also holds 390,317 shares of Questcor Pharmaceuticals, Inc. common stock, of which 291,317 shares are held directly by the reporting person. Options were granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan. The option was granted on 02/26/2009 for the right to buy 220,000 shares of common stock of the Issuer. The option provided for monthly vesting over 48 months from the date of grant, with a 12-month cliff, whereby no options vested until after the twelfth month from the date of the grant. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00-$ 61.96 and $62.05-$62.80, respectively. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan (the "Automatic Trading Plan") adopted by the reporting person in the second quarter of 2013 and effective 90 days post-adoption. There have been no changes to the Automatic Trading Plan since its adoption, and there have been no sales by the Reporting Person outside of the Automatic Trading Plan since its adoption. The Automatic Trading Plan controls the exact dates and amounts of sales. /s/Don M. Bailey 2013-11-15